Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Nasdaq Real Time Price USD

Tonix Pharmaceuticals Holding Corp. (TNXP)

Compare
19.94
-0.23
(-1.14%)
As of 11:16:17 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
10,094
10,094
7,768
--
--
Cost of Revenue
7,765
7,765
4,741
--
--
Gross Profit
2,329
2,329
3,027
--
--
Operating Expense
77,479
77,479
121,407
112,091
92,312
Operating Income
-75,150
-75,150
-118,380
-112,091
-92,312
Net Non Operating Interest Income Expense
751
--
--
1,873
25
Other Income Expense
-54,886
-54,886
1,722
1,873
--
Pretax Income
-130,036
-130,036
-116,658
-110,218
-92,287
Net Income Common Stockholders
-130,036
-130,036
-116,658
-116,877
-92,287
Diluted NI Available to Com Stockholders
-130,036
-130,036
-116,658
-116,877
-92,287
Basic EPS
-17.66k
--
-6.37k
-65.40k
-119.08k
Diluted EPS
-17.66k
--
-6.37k
-65.40k
-119.08k
Basic Average Shares
7.36
--
18.32
1.79
0.78
Diluted Average Shares
7.36
--
18.32
1.79
0.78
Total Operating Income as Reported
-136,701
-136,701
-118,380
-112,091
-92,312
Total Expenses
85,244
85,244
126,148
112,091
92,312
Interest Income
751
--
--
1,873
25
Net Interest Income
751
--
--
1,873
25
Net Income from Continuing & Discontinued Operation
-130,036
-130,036
-116,658
-110,218
-92,287
Normalized Income
-77,229
-77,229
-116,658
-110,218
-92,287
EBIT
-75,150
-75,150
-118,380
-112,091
-92,312
EBITDA
-71,729
-71,729
-114,089
-110,838
-92,262
Reconciled Cost of Revenue
7,765
7,765
4,741
--
--
Reconciled Depreciation
3,421
3,421
4,291
1,253
50
Net Income from Continuing Operation Net Minority Interest
-130,036
-130,036
-116,658
-110,218
-92,287
Total Unusual Items Excluding Goodwill
-52,807
-52,807
--
--
--
Total Unusual Items
-52,807
-52,807
--
--
--
Normalized EBITDA
-18,922
-18,922
-114,089
-110,838
-92,262
12/31/2021 - 5/10/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SLNO Soleno Therapeutics, Inc.
73.07
+1.50%
 
PRTG Portage Biotech Inc.
8.40
-12.50%
 
LXRX Lexicon Pharmaceuticals, Inc.
0.5780
+1.32%
 
OCEA Ocean Biomedical, Inc.
0.0550
-13.52%
 
OSRH OSR Holdings, Inc.
2.0200
-15.83%
 
RNAZ TransCode Therapeutics, Inc.
0.5300
+8.30%
 
SAVA Cassava Sciences, Inc.
1.5637
-5.23%
 
PSTV Plus Therapeutics, Inc.
0.9925
-14.44%
 
DRMA Dermata Therapeutics, Inc.
1.1700
-0.85%
 
MIST Milestone Pharmaceuticals Inc.
0.7916
-10.05%